Deciphera Pharmaceuticals' GAAP loss for 2021 was $299.964 million, up 12.6% from $266.489 million in the previous year. Revenue increased 2.3 times to $96.148 million from $42.087 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept